abstract |
The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL 5 KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC) 13 and wherein the peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, thereby forming a suspension, characterized in that the mean particle size of the solid particles is less than 1 μm. |